Steroid Pathway Genes and Neonatal Respiratory Distress After Betamethasone Use in Anticipated Preterm Birth
- PMID: 26507871
- PMCID: PMC5933159
- DOI: 10.1177/1933719115612129
Steroid Pathway Genes and Neonatal Respiratory Distress After Betamethasone Use in Anticipated Preterm Birth
Abstract
Objective: To test several key glucocorticoid genes that are enhanced in lung development for associations with respiratory distress syndrome (RDS) after antenatal corticosteroid use.
Methods: A prospective cohort of women received betamethasone to accelerate fetal lung maturity for threatened preterm delivery. DNA was obtained from mothers and newborns. Neonatal RDS was the primary outcome. Genotyping for single-nucleotide polymorphisms (SNPs) in 68 glucocorticoid genes found to be differentially expressed during lung development was performed. Multivariable analysis tested for associations of SNPs in the candidate genes with RDS.
Results: Genotypic results for 867 SNPs in 96 mothers and 73 babies were included. Thirty-nine (53.4%) babies developed RDS. Maternal SNPs in the centromeric protein E (CENPE), GLRX, CD9, and AURKA genes provided evidence of association with RDS (P < .01). In newborns, SNPs in COL4A3, BHLHE40, and SRGN provided evidence of association with RDS (P < .01).
Conclusion: Single-nucleotide polymorphisms in several glucocorticoid responsive genes suggest association with neonatal RDS after antenatal corticosteroid use.
Keywords: antenatal corticosteroid; pharmacogenetics; pregnancy; preterm labor.
© The Author(s) 2015.
Conflict of interest statement
References
-
- American College of Obstetricians and Gynecologists; Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 127: Management of preterm labor. Obstet Gynecol. 2012;119(6):1308–1317. - PubMed
-
- Frisbie WP, Song SE, Powers DA, Street JA. The increasing racial disparity in infant mortality: respiratory distress syndrome and other causes. Demography. 2004;41(4):773–800. - PubMed
-
- Tantisira K, Weiss S, Tantisira K, Weiss S. The pharmacogenetics of asthma treatment. Curr Allergy Asthma Rep. 2009;9(1):10–17. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL097144/HL/NHLBI NIH HHS/United States
- U10 HD063094/HD/NICHD NIH HHS/United States
- R01HL097144/HL/NHLBI NIH HHS/United States
- U01 HL065899/HL/NHLBI NIH HHS/United States
- R01 HL092197/HL/NHLBI NIH HHS/United States
- U01HL65899/HL/NHLBI NIH HHS/United States
- R01HL092197/HL/NHLBI NIH HHS/United States
- K25 HL091124/HL/NHLBI NIH HHS/United States
- K23 HD055305/HD/NICHD NIH HHS/United States
- 5U01HD063094/HD/NICHD NIH HHS/United States
- K08 HL096833/HL/NHLBI NIH HHS/United States
- K08HL096833/HL/NHLBI NIH HHS/United States
- 5K23HD055305/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous